Mupirocin and Ocular hyperaemia - a phase IV clinical study of FDA data

Summary:

Ocular hyperaemia is reported as a side effect among people who take Mupirocin (mupirocin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Dupixent, and have Dermatitis atopic.

The phase IV clinical study analyzes which people have Ocular hyperaemia when taking Mupirocin. It is created by eHealthMe based on reports of 5,867 people who have side effects when taking Mupirocin from the FDA, and is updated regularly.

What is Mupirocin?

Mupirocin has active ingredients of mupirocin. It is often used in impetigo. eHealthMe is studying from 5,940 Mupirocin users. Check the latest studies of Mupirocin.

What is Ocular hyperaemia?

Ocular hyperaemia (an abnormally large amount of blood in eye) is found to be associated with 1,356 drugs and 1,499 conditions by eHealthMe. Check the latest studies of Ocular hyperaemia.

On Jul, 18, 2026

5,867 people reported to have side effects when taking Mupirocin.
Among them, 32 people (0.55%) have Ocular hyperaemia.

Could Mupirocin cause Ocular hyperaemia?

Among these 32 people:

How long have people been on Mupirocin when they have Ocular hyperaemia? *

What is the gender of people who have Ocular hyperaemia when taking Mupirocin? *

female: 60 %
male: 40 %

What is the age of people who have Ocular hyperaemia when taking Mupirocin? *

What are other drugs people take besides Mupirocin? *

What are other side effects people have besides Ocular hyperaemia? *

Rashes (redness): 13 people, 40.62%
Eye Pruritus (eye itching): 10 people, 31.25%
Lacrimation Increased: 8 people, 25.00%
Dry Eyes (lack of adequate tears): 6 people, 18.75%
Thrombocytopenia (decrease of platelets in blood): 6 people, 18.75%
Itching: 6 people, 18.75%
Vision Blurred: 6 people, 18.75%
Eye Swelling: 6 people, 18.75%
Eye Irritation: 5 people, 15.62%
Conjunctivitis (pink eye): 5 people, 15.62%

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 11 people, 34.38%
Asthma: 6 people, 18.75%
Primary Immunodeficiency Syndrome: 3 people, 9.38%
Laxative Supportive Care: 3 people, 9.38%
Multiple Myeloma (cancer of the plasma cells): 3 people, 9.38%
Rosacea (a skin condition that causes facial redness): 1 person, 3.12%
Polyp: 1 person, 3.12%
Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 3.12%
Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 1 person, 3.12%
Nasal Polyps (masses that develop in the lining of the nose): 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Mupirocin and have Ocular hyperaemia?

- Check whether Ocular hyperaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mupirocin:

Mupirocin (5,940 reports)

Browse all side effects of Mupirocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ocular hyperaemia:

Ocular hyperaemia (1,356 drugs)

Browse all the conditions that are associated with Ocular hyperaemia:

Ocular hyperaemia (1,499 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mupirocin (the active ingredients of Mupirocin) and Mupirocin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.